Literature DB >> 18297128

Diversity of interferon gamma and granulocyte-macrophage colony-stimulating factor in restoring immune dysfunction of dendritic cells and macrophages during polymicrobial sepsis.

Stefanie B Flohé1, Hemant Agrawal, Sascha Flohé, Meenakshi Rani, Jörg M Bangen, F Ulrich Schade.   

Abstract

The development of immunosuppression during polymicrobial sepsis is associated with the failure of dendritic cells (DC) to promote the polarization of T helper (Th) cells toward a protective Th1 type. The aim of the study was to test potential immunomodulatory approaches to restore the capacity of splenic DC to secrete interleukin (IL) 12 that represents the key cytokine in Th1 cell polarization. Murine polymicrobial sepsis was induced by cecal ligation and puncture (CLP). Splenic DC were isolated at different time points after CLP or sham operation, and stimulated with bacterial components in the presence or absence of neutralizing anti-IL-10 antibodies, murine interferon (IFN) gamma, and/or granulocyte macrophage colony-stimulating factor (GM-CSF). DC from septic mice showed an impaired capacity to release the pro-inflammatory and Th1-promoting cytokines tumor necrosis factor alpha, IFN-gamma, and IL-12 in response to bacterial stimuli, but secreted IL-10. Endogenous IL-10 was not responsible for the impaired IL-12 secretion. Up to 6 h after CLP, the combined treatment of DC from septic mice with IFN-gamma and GM-CSF increased the secretion of IL-12. Later, DC from septic mice responded to IFN-gamma and GM-CSF with increased expression of the co-stimulatory molecule CD86, while IL-12 secretion was no more enhanced. In contrast, splenic macrophages from septic mice during late sepsis responded to GM-CSF with increased cytokine release. Thus, therapy of sepsis with IFN-gamma/GM-CSF might be sufficient to restore the activity of macrophages, but fails to restore DC function adequate for the development of a protective Th1-like immune response.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297128      PMCID: PMC2249752          DOI: 10.2119/2007-00120.Flohe

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  45 in total

1.  CD11c+ dendritic cells are required for survival in murine polymicrobial sepsis.

Authors:  Philip O Scumpia; Priscilla F McAuliffe; Kerri A O'Malley; Ricardo Ungaro; Takefumi Uchida; Tadashi Matsumoto; Daniel G Remick; Michael J Clare-Salzler; Lyle L Moldawer; Philip A Efron
Journal:  J Immunol       Date:  2005-09-01       Impact factor: 5.422

2.  Monocyte anergy is present in patients with severe acute pancreatitis and is significantly alleviated by granulocyte-macrophage colony-stimulating factor and interferon-gamma in vitro.

Authors:  Marja-Leena Kylanpaa; Panu Mentula; Esko Kemppainen; Pauli Puolakkainen; Saara Aittomaki; Olli Silvennoinen; Reijo Haapiainen; Heikki Repo
Journal:  Pancreas       Date:  2005-07       Impact factor: 3.327

Review 3.  Dendritic cells and the control of immunity.

Authors:  J Banchereau; R M Steinman
Journal:  Nature       Date:  1998-03-19       Impact factor: 49.962

4.  T helper cell subset ratios in patients with severe sepsis.

Authors:  N R Ferguson; H F Galley; N R Webster
Journal:  Intensive Care Med       Date:  1999-01       Impact factor: 17.440

5.  Reversal of long-term sepsis-induced immunosuppression by dendritic cells.

Authors:  Claudia F Benjamim; Steven K Lundy; Nicholas W Lukacs; Cory M Hogaboam; Steven L Kunkel
Journal:  Blood       Date:  2004-12-16       Impact factor: 22.113

6.  Effect of granulocyte-monocyte colony-stimulating factor therapy on leukocyte function and clearance of serious infection in nonneutropenic patients.

Authors:  Alan J Rosenbloom; Peter K Linden; Adrienne Dorrance; Nicole Penkosky; Mark H Cohen-Melamed; Michael R Pinsky
Journal:  Chest       Date:  2005-06       Impact factor: 9.410

7.  Influence of granulocyte-macrophage colony-stimulating factor (GM-CSF) on whole blood endotoxin responsiveness following trauma, cardiopulmonary bypass, and severe sepsis.

Authors:  S Flohé; J Börgermann; F E Domínguez; M Majetschak; L Lim; E Kreuzfelder; U Obertacke; D Nast-Kolb; F U Schade
Journal:  Shock       Date:  1999-07       Impact factor: 3.454

8.  Sepsis induces apoptosis and profound depletion of splenic interdigitating and follicular dendritic cells.

Authors:  Kevin W Tinsley; Mitchell H Grayson; Paul E Swanson; Anne M Drewry; Katherine C Chang; Irene E Karl; Richard S Hotchkiss
Journal:  J Immunol       Date:  2003-07-15       Impact factor: 5.422

9.  Activation of mitogen-activated protein kinase cascades during priming of human neutrophils by TNF-alpha and GM-CSF.

Authors:  K R McLeish; C Knall; R A Ward; P Gerwins; P Y Coxon; J B Klein; G L Johnson
Journal:  J Leukoc Biol       Date:  1998-10       Impact factor: 4.962

10.  Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10.

Authors:  M Aste-Amezaga; X Ma; A Sartori; G Trinchieri
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

View more
  18 in total

1.  Additive effects of exogenous IL-12 supplementation and antibiotic treatment in infection prophylaxis.

Authors:  Brandon M Boyce; Brock A Lindsey; Nina B Clovis; E Suzanne Smith; Gerald R Hobbs; David F Hubbard; Sanford E Emery; John B Barnett; Bingyun Li
Journal:  J Orthop Res       Date:  2011-08-03       Impact factor: 3.494

Review 2.  Immunomodulatory therapies for acute pancreatitis.

Authors:  Jing Li; Wen-Juan Yang; Lu-Ming Huang; Cheng-Wei Tang
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

3.  Lipopeptides rather than lipopolysaccharide favor the development of dendritic cell dysfunction similar to polymicrobial sepsis in mice.

Authors:  Stephanie Bruns; Eva Pastille; Florian Wirsdörfer; Marion Frisch; Stefanie B Flohé
Journal:  Inflamm Res       Date:  2013-04-03       Impact factor: 4.575

Review 4.  Role of cellular events in the pathophysiology of sepsis.

Authors:  Chandra Bhan; Pankaj Dipankar; Papiya Chakraborty; Pranita P Sarangi
Journal:  Inflamm Res       Date:  2016-07-08       Impact factor: 4.575

5.  Sepsis in the pediatric cardiac intensive care unit.

Authors:  Derek S Wheeler; Howard E Jeffries; Jerry J Zimmerman; Hector R Wong; Joseph A Carcillo
Journal:  World J Pediatr Congenit Heart Surg       Date:  2011-07-01

6.  Effect of Cholecalciferol Supplementation on Vitamin D Status and Cathelicidin Levels in Sepsis: A Randomized, Placebo-Controlled Trial.

Authors:  Sadeq A Quraishi; Gennaro De Pascale; Joseph S Needleman; Harumasa Nakazawa; Masao Kaneki; Ednan K Bajwa; Carlos A Camargo; Ishir Bhan
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

Review 7.  Novel pharmacologic approaches to the management of sepsis: targeting the host inflammatory response.

Authors:  Derek S Wheeler; Basilia Zingarelli; William J Wheeler; Hector R Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2009-06

Review 8.  Perturbed mononuclear phagocyte system in severely burned and septic patients.

Authors:  Fangming Xiu; Marc G Jeschke
Journal:  Shock       Date:  2013-08       Impact factor: 3.454

9.  Sepsis: multiple abnormalities, heterogeneous responses, and evolving understanding.

Authors:  Kendra N Iskander; Marcin F Osuchowski; Deborah J Stearns-Kurosawa; Shinichiro Kurosawa; David Stepien; Catherine Valentine; Daniel G Remick
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

Review 10.  Estrogen receptor agonists for attenuation of neuroinflammation and neurodegeneration.

Authors:  Mrinmay Chakrabarti; Azizul Haque; Naren L Banik; Prakash Nagarkatti; Mitzi Nagarkatti; Swapan K Ray
Journal:  Brain Res Bull       Date:  2014-09-20       Impact factor: 4.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.